free web stats
Category

Glioblastoma (“GBM”)

VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at the Immuno-Oncology Summit

By | Conferences, Glioblastoma ("GBM"), Press Releases
IND-enabling data, including restimulation of CMV-specific T-cell immunity in Rhesus Macaques Mechanistic data demonstrating VBI-1901 stimulates innate immunity Data presentation Wednesday, August 30, 2017 VBI Vaccines Inc. (Nasdaq: VBIV) (TSX: VBV) (VBI), today announced that David Anderson, Ph.D., Chief Scientific...
Read More

VBI Presents New Data Supporting its Glioblastoma Immunotherapy Program at the Keystone Symposia Cancer Vaccines Conference

By | Conferences, Glioblastoma ("GBM"), Press Releases
VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) today will present new data supporting its glioblastoma multiforme (“Glioblastoma” or “GBM”) cancer immunotherapy program at the Keystone Symposia Cancer Vaccines Conference taking place in Whistler, British Columbia, Canada. Keystone Symposia are peer-reviewed conferences that...
Read More